Orumaa M - Search Results

1

Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015.

Hansen BT, Orumaa M, Lie AK, Brennhovd B, Nygård M. Hansen BT, et al. Among authors: orumaa m. Int J Cancer. 2018 Apr 15;142(8):1586-1593. doi: 10.1002/ijc.31194. Epub 2017 Dec 15. Int J Cancer. 2018. PMID: 29205336 Free PMC article.

2

Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.

Orumaa M, Leinonen MK, Campbell S, Møller B, Myklebust TÅ, Nygård M. Orumaa M, et al. Int J Cancer. 2019 Nov 15;145(10):2629-2638. doi: 10.1002/ijc.32195. Epub 2019 Mar 4. Int J Cancer. 2019. PMID: 30734284 Free PMC article.

3

The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.

Orumaa M, Kjaer SK, Dehlendorff C, Munk C, Olsen AO, Hansen BT, Campbell S, Nygård M. Orumaa M, et al. Vaccine. 2020 Feb 5;38(6):1345-1351. doi: 10.1016/j.vaccine.2019.12.016. Epub 2020 Jan 6. Vaccine. 2020. PMID: 31917039 Free article.

4

Cervical cancer screening history among women diagnosed with cervical cancer in Estonia 2017-18.

Orumaa M, Innos K, Suurna M, Veerus P. Orumaa M, et al. Eur J Public Health. 2023 Feb 3;33(1):64-68. doi: 10.1093/eurpub/ckac176. Eur J Public Health. 2023. PMID: 36469798 Free PMC article.

5

Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.

Nõmm O, Veerus P, Orumaa M, Innos K. Nõmm O, et al. Among authors: orumaa m. Cancer Epidemiol. 2022 Oct;80:102231. doi: 10.1016/j.canep.2022.102231. Epub 2022 Jul 25. Cancer Epidemiol. 2022. PMID: 35901623

6

HPV-associated cancers among people living with HIV: nationwide population-based retrospective cohort study 2004-21 in Estonia.

Tisler A, Toompere K, Bardou M, Diaz J, Orumaa M, Uusküla A. Tisler A, et al. Among authors: orumaa m. Eur J Public Health. 2024 Dec 1;34(6):1199-1204. doi: 10.1093/eurpub/ckae152. Eur J Public Health. 2024. PMID: 39378418 Free PMC article.

7

Quadrivalent HPV Vaccine Effectiveness Against Cervical Intraepithelial Lesion Grade 2 or Worse in Norway: A Registry-Based Study of 0.9 Million Norwegian Women.

Orumaa M, Lahlum EJ, Gulla M, Tota JE, Nygård M, Nygård S. Orumaa M, et al. J Infect Dis. 2024 Dec 16;230(6):e1202-e1206. doi: 10.1093/infdis/jiae209. J Infect Dis. 2024. PMID: 38658353 Free PMC article.

8

Erratum to "Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals" [Vaccine 41(37) (2023) 5469-5476].

Nygård S, Nygård M, Orumaa M, Hansen BT. Nygård S, et al. Among authors: orumaa m. Vaccine. 2023 Sep 22;41(41):6134. doi: 10.1016/j.vaccine.2023.08.056. Epub 2023 Aug 26. Vaccine. 2023. PMID: 37640570 Free article. No abstract available.

9

Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.

Nygård S, Nygård M, Orumaa M, Hansen BT. Nygård S, et al. Among authors: orumaa m. Vaccine. 2023 Aug 23;41(37):5469-5476. doi: 10.1016/j.vaccine.2023.07.031. Epub 2023 Jul 27. Vaccine. 2023. PMID: 37516572 Free article.

10

Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.

Suurna M, Orumaa M, Ringmets I, Pärna K. Suurna M, et al. Among authors: orumaa m. BMC Womens Health. 2022 Dec 24;22(1):545. doi: 10.1186/s12905-022-02123-z. BMC Womens Health. 2022. PMID: 36566176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters